Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes

Endocrine Journal

Volumn 55, Issue 3, 2008, Pages 503-507

  Yoshiuchi, Kazutomi ^a   Matsuhisa, Munehide ^a,c   Katakami, Naoto ^a   Nakatani, Yoshihisa ^a   Sakamoto, Kenya ^a   Matsuoka, Takaaki ^a   Umayahara, Yutaka ^b   Kosugi, Keisuke ^b   Kaneto, Hideaki ^a   Yamasaki, Yoshimitsu ^a   Hori, Masatsugu ^a  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA POLICE HOSPITAL   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Glycated albumin; Glycemic excursion; HbA1c

Indexed keywords

GLUCOSE; GLYCOSYLATED ALBUMIN; GLYCOSYLATED HEMOGLOBIN; GLYCOSYLATED PROTEIN; HEMOGLOBIN A1C;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; EVALUATION; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; STATISTICAL SIGNIFICANCE;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CIRCADIAN RHYTHM; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; PROGNOSIS; SERUM ALBUMIN;

EID: 46749094241     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K07E-089     Document Type: Article

References (20)

1. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, N Engl J Med 329: 977-986.
2. UK Prospective Diabetes Study Group (1998) Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS33), Lancet 352: 837-853,
3. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M (1995) Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study. Diabetes Res Clin Pract 28: 103-117.
4. Bunn HF, Haney DN, Kamin S, Gabbay KH, Gallop PM (1976) The biosynthesis of human hemoglobin Alc: slow glycosylation of hemoglobin in vivo. J Clin Invest 57: 1652-1659.
5. Stevens VJ, Vlassara H, Abati A, Cerami A (1977) Nonenzymatic glycosylation of hemoglobin. J Biol Chem 252: 2998-3002.
6. Virtue MA, Nuttall FQ, Furne JK, Levitt MA (2004) Relationship between GHb concentration and erythrocyte survival determined from breath carbon monoxide concentration. Diabetes Care 27: 931-935.
7. Goldstein DE, Little RR, Lorenz RA, Malone JI, Nathan D, Peterson CM, Sacks DB (2004) Tests of glycemia in diabetes. Diabetes Care 27: 1761-1773.
8. The Diabetes Control and Complications Trial Research Group (1995) The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes 44: 968-983.
9. Shiraiwa T, Kaneto H, Miyatsuka T, Kato K, Yamamoto K, Kawashima A, Kanda T, Suzuki M, Imano E, Matsuhisa M, Hori M, Yamasaki Y (2005) Postprandial hyperglycemia is a better predictor of the progression of diabetic retinopathy than HbA1C in Japanese Type2 diabetic patients. Diabetes Care 28: 2806-2807.
10. Hanefeld M, Fischer S, Julius U, Schwanebeck U, Schmechel H Ziegelasch HJ, Linder J (1996) Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11 -year follow-up. Diabetologia 39: 1577-1583.
11. Hanefeld M, Cagatay M, Petrowitsch T, Neuser D, Petzinna D, Rupp M (2004) Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies. European Heart Journal 25: 10-16.
12. Jones IR, Owens DR, Williams S, Ryder RE, Birtwell AJ, Jones MK, Gicheru K, Hayes TM (1983) Glycosylated serum albumin: an intermediate index of diabetic control. Diabetes Care 6: 501-503.
13. Schultze HE, Hetermans JF (1966) Molecular Biology of Human Proteins. Amsterdam, New York, Elsevier/North Holland. 1:475.
14. Takahashi S, Uchino H, Shimizu T, Kanazawa A, Tamura Y, Sakai K, Watada H, Hirose T, Kawamori R (2007) Comparison of glycated albumin (GA) and glycated hemoglobin (HbAlc) in type 2 diabetic patients: Usefulness of GA for evaluation of short-term changes in glycemic control. Endocr J 54: 139-144.
15. Iberg N, Fluckiger R (1986) Nonenzymatic glycosylation of albumin in vivo. Identification of multiple glycpsylated sites. J Biol Chem 261: 13542-13545.
16. Garlick RL, Mazer JS (1983) The principal site of nonenzymatic glycosylation of human serum albumin in vivo. J Biol Chem 258: 6142-6146.
17. Kouzuma T, Usami T, Yamakoshi M, Takahashi M, Imamura S (2002) An enzymatic method for the measurement of glycated albumin in biological samples. Clin Chim Acta 324: 61-71.
18. Service FJ, Molnar GD, Rosevear JW (1970) Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 9: 644-655.
19. Koga M, Matsumoto S, Saito H and Kasayama S (2006) Body mass index negatively influences glycated albumin, but not glycated hemoglobin, in diabetes patients. Endocr J 53: 387-391.
20. Monnier L, Lapinski H, Colette C (2003) Contribution of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients. Diabetes Care 26: 881-885.